吉林要如何治疗儿童包皮过长-【吉林协和医院】,JiXiHeyi,吉林做包皮手术到哪家医院权威,吉林治疗尿道炎医院男子医院,吉林什么医院看男科比较专业,吉林阴茎上有小红点,吉林医院怎么提高性生活质量,吉林包皮整形要多少钱

LOS ANGELES, May 12 (Xinhua) -- A subsurface ocean of molten or partially molten magma exists beneath the surface of Jupiter's volcanic moon Io, the Jet Propulsion Laboratory (JPL) said on Thursday."The finding heralds the first direct confirmation of this kind of magma layer at Io and explains why the moon is the most volcanic object known in the solar system," JPL said in a press release posted on its website.The finding was based on new data analysis from NASA's Galileo spacecraft, said JPL.The research was conducted by scientists at the University of California, Los Angeles; the University of California, Santa Cruz;, and the University of Michigan, Ann Arbor. The study is published this week in the journal Science, JPL said."Scientists are excited we finally understand where Io's magma is coming from and have an explanation for some of the mysterious signatures we saw in some of the Galileo's magnetic field data," said Krishan Khurana, lead author of the study and former co- investigator on Galileo's magnetometer team at UCLA."It turns out Io was continually giving off a 'sounding signal' in Jupiter's rotating magnetic field that matched what would be expected from molten or partially molten rocks deep beneath the surface."Io produces about 100 times more lava each year than all the volcanoes on Earth, according to data released by JPL in Pasadena, Los Angeles.While Earth's volcanoes occur in localized hotspots like the "Ring of Fire" around the Pacific Ocean, Io's volcanoes are distributed all over its surface, JPL said, adding that a global magma ocean about 30 to 50 km beneath Io's crust helps explain the moon's activity."It has been suggested that both the Earth and its moon may have had similar magma oceans billions of years ago at the time of their formation, but they have long since cooled," said Torrence Johnson, a former Galileo project scientist based at JPL, an affiliation with NASA."Io's volcanism informs us how volcanoes work and provides a window in time to styles of volcanic activity that may have occurred on the Earth and moon during their earliest history," said Johnson, who was not directly involved in the study.NASA's Voyager spacecraft discovered Io's volcanoes in 1979, making that moon the only body in the solar system other than Earth known to have active magma volcanoes. The energy for the volcanic activity comes from the squeezing and stretching of the moon by Jupiter's gravity as Io orbits the largest planet in the solar system.Galileo was launched in 1989 and began orbiting Jupiter in 1995. Unexplained signatures appeared in magnetic field data from Galileo flybys of Io in October 1999 and February 2000. After a successful mission, the spacecraft was intentionally sent into Jupiter's atmosphere in 2003.
BEIJING, March 24 (Xinhuanet) -- A new study has found that Actos, a medicine treats onset diabetes, could also reduce the diabetes risk in people with prediabetes.The study, which was published Wednesday in New England Journal of Medicine, followed 602 prediabetics whose obesity, ethnicity, family history and other factors put them at high risk of developing diabetes.The research findings showed that Actos, generically known as pioglitazone, reduced the odds of developing Type 2 diabetes by 72 percent in people with prediabetes.Only 2.1 percent of those who took Actos developed diabetes each year over the three years of the study, compared with 7.6 percent of those who took a placebo.Lead author of the study Ralph DeFronzo said, "The 72 percent reduction is the largest decrease in the conversion rate of pre-diabetes to (Type 2) diabetes that has ever been demonstrated by any intervention, be it diet, exercise or medication."However, Actos can have significant side effects, including water retention, moderate weight gain, and increased risk of bone fractures.

JERUSALEM, March 31 (Xinhua) -- Two researchers at the Hebrew University (HU) of Jerusalem have been honored with a prestigious award for their study of the connection between several inflammatory diseases, cancer and bacteria.Medical faculty members, Dr. Eli Pilarsky and Prof. Sigal Ben- Yehuda, won this year's Sir Zelman Cowen Universities Fund prize that recognizes significant achievement in the field of medicine.The prize committee noted the impressive contributions of Pilarsky and Ben-Yehuda in understanding complex diseases like cancer and antibiotic-resistant infections, and, in a first, decided to award the two scientists this year.Pilarsky told Xinhua that his research deals with the connection between chronic inflammatory diseases like hepatitis, and the development of cancer cells."The relevance of this discovery is that we were able to establish the link between the molecules secreted with such inflammations and the proliferation of cancer cells," Pilarsky explained, noting that "we discovered that the inflammation favors the cancer cells' growth, and now we are trying to find a way to manipulate these molecules to stop the cancer cells from appearing. ""The importance of these findings lies in the fact that 20 percent of the world's cancer cases are attributed to inflammation processes," Pilarsky pointed out.
BEIJING, March 10 (Xinhuanet) -- The price of preventing preterm labor is about to rise drastically in the U.S. next week.A drug for high-risk pregnant women costs about 10 to 20 dollars per injection. Next week, the price will shoot up to 1,500 dollars a dose, according to media reports Wednesday.This means the total cost during a pregnancy could be as much as 30,000 dollars.The massive increase comes after KV Pharmaceutical of St. Louis won an exclusive government license to produce the drug, known as Makena.The drug, a form of progesterone given as a weekly shot, has been made cheaply for years by unlicensed chemists.The March of Dimes and many obstetricians supported the move because it means quality will be more consistent and it will be easier to get, but none of them has anticipated the sharp price hike.Doctors and campaign groups have been caught out by the move, saying that the price hike may deter low-income women from getting the drug, leading to more premature births.
来源:资阳报